, Eric M. Isselbacher2, Eric M. Isselbacher3 and Eric M. Isselbacher4
(1)
Harvard Medical School Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
(2)
Harvard Medical School, Boston, USA
(3)
MGH Heart Center, Boston, USA
(4)
MGH Thoracic Aortic Center Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
Abstract
The aorta is the largest artery in the body and diseases of the aorta, such as aneurysms, typically remain asymptomatic and undetected until either discovered incidentally on an imaging study or the development of an acute complication. When detected, both thoracic and abdominal aortic aneurysms should be followed carefully on serial imaging studies until large enough to merit intervention. In recent years, endovascular approaches have offered important alternatives to traditional open surgical techniques. Various classes of cardiac medications may have salutary effects on the aorta and can be used to reduce stress on the aorta and even improve vascular remodeling. The aorta is also affected by a number of congenital conditions as well as autoimmune vasculitides. For aortic coarctation, please refer to Chap. 21.
Abbreviations
AAA
Abdominal aortic aneurysm
ACC/AHA
American College of Cardiology/American Heart Association
ACEI
Angiotensin converting enzyme inhibitor
ACS
Acute coronary syndrome
AI
Aortic insufficiency
AS
Aortic stenosis
AV
Aortic valve
AVR
Aortic valve replacement
BAV
Bicuspid aortic valve
BP
Blood pressure
bpm
Beats per minutes
CABG
Coronary artery bypass graft
cm
Centimeter
CT(A)
Computed tomogram (angiography)
CXR
Chest x-ray
dP/dt
Change in pressure over change in time which is a measure of left ventricle ejection impulse, an index of shear stress on the aortic wall
DTAA
Descending thoracic aortic aneurysm
EVAR
Endovascular aortic aneurysm repair
GCA
Giant cell arteritis
HF
Heart failure
HR
Heart rate
IMA
Inferior mesenteric artery
IMH
Intramural hematoma of the aorta
IRAD
International Registry of Acute Aortic Dissection
LDL
Low density lipoprotein
LR
Likelihood ratio
M:F
Male to female ratio
mmHg
Millimeters of mercury
MMP
Matrix metalloproteinase
MR
Magnetic resonance
PAD
Peripheral artery disease
PAU
Penetrating atherosclerotic ulcer of the aorta
SBP
Systolic blood pressure
SD
Standard deviation
SMA
Superior mesenteric artery
STS
Society of Thoracic Surgeons
SVC
Superior vena cava
TAA
Thoracic aortic aneurysm
TAAA
Thoracoabdominal aortic aneurysm
TEE
Transesophageal echocardiography
TEVAR
Thoracic endovascular aortic repair
TGF
Transforming growth factor
TIA
Transient ischemic attack
TTE
Transthoracic echocardiography
USPSTF
United States Preventive Services Task Force
Introduction
The aorta is the largest artery in the body and diseases of the aorta, such as aneurysms, typically remain asymptomatic and undetected until either discovered incidentally on an imaging study or the development of an acute complication. When detected, both thoracic and abdominal aortic aneurysms should be followed carefully on serial imaging studies until large enough to merit intervention. In recent years, endovascular approaches have offered important alternatives to traditional open surgical techniques. Various classes of cardiac medications may have salutary effects on the aorta and can be used to reduce stress on the aorta and even improve vascular remodeling. The aorta is also affected by a number of congenital conditions as well as autoimmune vasculitides. For aortic coarctation, please refer to Chap. 21.
Aortic Anatomy
The largest artery in the body; muscular
Histologically contains three layers:
Intima (endothelium supported by internal elastic lamina)
Media (smooth muscle cells and numerous elastic fibers that give the aorta remarkable tensile strength)
Adventitia (collagenous support matrix with external elastic lamina, and site of entry of the vasa vasorum externae)
The segments of the aorta are differentiated by their anatomic location, size, and branch vessels (Table 11-1). Dimensions in males are slightly larger than in females, and the aortic diameters generally increase with age.
Table 11-1
Aorta anatomy
Aortic segments
Divisions
Approximate diameters (cm)
Major branch arteries
Ascending
Root (sinuses of Valsalva)
≤4.0
Right and left main coronary arteries
Ascending aorta
≤3.5
None
Arch
≤3.0
Brachiocephalic (innominate), left subclavian, and left common carotid arteries
Descending
≤2.5
Intercostal, spinal, bronchial arteries
Abdominal
Suprarenal
≤2.0
Celiac axis, SMA, and renal arteries
Infrarenal
≤2.0
IMA, common iliac arteries
General History and Physical Examination
Relevant history:
Due to aorta: Chest, back, abdominal, flank pain or discomfort.
Due to complications of aortic disease
Depends on the segment of the aorta affected and branch vessels and distal organ territories that are impacted.
Look for neurological symptoms, syncope, heart failure, myocardial infarction, renal failure, thromboembolic disease, compression of adjacent structures such as nerves, esophagus or tracheobronchial tree.
Past medical history aortic disease, vascular disease, hypertension (HTN), thromboembolic events, trauma
Family history: aortic disease
Physical examination:
Bilateral blood pressure (BP) and pulses (radial, carotid, femoral), pulsus paradoxus
Look for evidence of aortic insufficiency (AI), tamponade, heart failure and neurological deficit, pulsatile abdominal mass
Imaging Modalities
Chest Radiography (CXR)
CXR has overall limited sensitivity (∼30–60 %) for thoracic aortic aneurysm, and alone cannot be used to exclude acute or chronic aortopathy.
Calcification or tortuosity of the ascending, arch, and descending thoracic aorta may be visualized, but this is a non-specific finding in the elderly.
Opacification of the aorticopulmonary window, enlargement of the thoracic aorta, increased mediastinal width, displacement of trachea from midline, or obscured/irregular aortic margin may indicate thoracic aortic aneurysm, dissection, or rupture. Displaced intimal calcium and pleural effusion may indicate dissection.
Echocardiography and Ultrasonography
Portable, avoids radiation and contrast media, and can be deployed intra-operatively.
Transthoracic Echocardiography (TTE)
TTE cannot provide a comprehensive exam of the aorta, but certain regions can be visualized: aortic valve and root, ascending aorta, arch, descending, and abdominal aorta
TTE is reasonable for assessing aortic valve disorders and monitoring aortic root and ascending aortic dilatation (e.g. especially in Marfan syndrome). It is not sensitive enough to rule out thoracic aortic dissection (sensitivity 70 %).
Transesophageal Echocardiography (TEE)
TEE can visualize the ascending aorta, transverse arch, and entire descending thoracic aorta. The distal ascending aorta and proximal aortic arch may be obscured by the trachea.
TEE, in contrast to other modalities, can provide functional information such as flow dynamics in true and false lumens, detection of AI, detection of cardiac tamponade, and assessment of left ventricular function.
Abdominal ultrasonography is the technique of choice for screening for infrarenal abdominal aortic aneurysm (AAA), but is less accurate as applied to the suprarenal aorta or branch vessels.
Computed Tomography (CT)
CT is a highly accurate, rapid, reproducible, and readily available technique for detecting and sizing aortic aneurysms and for the diagnostic evaluation of suspected aortic dissection.
CT is also helpful at mapping branch vessels, and for detecting mimics of aortic disease (e.g. pericardial disease, gastrointestinal disease).
Magnetic Resonance (MR) Imaging
MR is also a highly accurate technique for aortic imaging. However, the study time is lengthy and the patient is relatively inaccessible, making this modality unsuitable for acute or unstable patients.
MR is most often performed with intravenous gadolinium as a contrast agent, but the “black-blood” technique with spin-echo sequences can provide satisfactory images without the need for gadolinium.
Aortography
Catheter-based aortography is an invasive technique that can demonstrate the full extent of aneurysmal disease and dissection, map branch vessel involvement, and demonstrate the presence of AI.
However, aortography is not readily available in most settings, requires an expert physician operator, and requires that potentially unstable patients undergo a prolonged procedure.
Aortic Aneurysms
Definitions
Aneurysm = dilatation of the aorta involving all three vessel wall layers. Pseudoaneurysm = contained leak of blood in communication with vessel.
Fusiform = symmetric circumferential bulging of the aorta. Saccular = asymmetric localized bulging of the aortic wall.
Abdominal Aortic Aneurysms (AAA)
Epidemiology: up to 3 % prevalence >50 years, and 5 % >65 years, with M:F ratio up to 10:1 [1].
Infrarenal AAA represents the most common location.
Etiology [2]:
Chief pathophysiologic factors are atherosclerosis and smoking. Male gender, advanced age, dyslipidemia, and family history also contribute.
Inflammation, both primary or secondary to atherosclerosis, is increasingly recognized as a key factor that results in oxidative stress in the aortic media, deterioration of aortic tensile properties, and apoptosis of smooth muscle cells.
There is an increased prevalence of AAA among first-degree relatives of affected individuals. Genetic basis still unclear (may include structural proteins, proteases such as matrix metalloproteinases (MMP), or immunomodulatory genes).
Bacteria and mycobacteria can generate infectious (also known as mycotic) aneurysms.
History and Examination [3, 4]
Most AAA are asymptomatic, and diagnosed on physical examination or incidentally on imaging.
Patients may have persistent pain in the lower abdomen or lower back, with a “gnawing” character.
New or worsening pain may herald AAA expansion or rupture.
Classic triad of AAA rupture = pain, hypotension, and pulsatile abdominal mass.
Space-occupying effects of AAA include extremity ischemia, gastrointestinal or ureteral obstruction.
Palpation of a pulsatile mass may help detect AAAs large enough to merit repair (sensitivity 68 %, positive predictive value 43 %), but alone is not sufficient to exclude AAA.
Sensitivity correlates with AAA diameter (61 % for 3.0–3.9 cm, 82 % for >5.0 cm), but sensitivity decreases with obesity.
Palpation maneuvers for AAA are not believed to cause rupture.
Auscultation of bruits does not help diagnose AAA.
Screening and Diagnosis
Screening by exam and ultrasound is recommended by American College of Cardiology (ACC)/American Heart Association (AHA) (class I in 2006 guidelines) for males above age 60 who are siblings or offspring of parents with AAA.
The United States Preventive Services Task Force (USPSTF) recommends abdominal ultrasonography screening for infrarenal AAA in all males age 65–74 who have ever smoked (ACC/AHA 2006 guidelines IIa recommendation)
There are no recommendations for screening females or older males.
Prognosis: Risk of rupture varies with size. Annual risks are 0.3 % for AAA diameter <4.0 cm, 1.5 % for 4.0–4.9 cm, and 6.5 % for 5.0–5.9 cm [5].
Females with AAA have a greater risk of rupture than males, and experience rupture at smaller AAA diameters.
Overall mortality from AAA rupture >50–80 %.
Mural thrombus within an AAA is associated with increased rates of growth and cardiovascular events.
Medical Treatment
Smoking cessation and lipid control (LDL goal <70 mg/dL) is essential.
Studies of statins in AAA suggest possible reduction in AAA growth.
Aspirin, reduction in BP, and reduction of dP/dt are reasonable.
Beta-blockers carry a IIa recommendation for reducing the rate of AAA growth. For repair of atherosclerotic AAA, perioperative beta-blockade has a class I indication.
Angiotensin converting enzyme inhibitors (ACEI) may, in addition to BP reduction, reduce rate of AAA rupture.
Several studies have hinted a role for macrolide and tetracycline antibiotics based on a possible effect on Chlamydophila (previously thought to be important in AAA pathogenesis), and for anti-inflammatory and anti-metalloproteinase properties. However, such therapies are not yet recommended for clinical use.
AAA Repair [3]:
Indications: given high mortality from ruptured AAA, prophylactic repair should be undertaken when infrarenal AAA ≥5.5 cm in males and 5.0 cm in females. Infrarenal AAA of 4.0–5.4 cm should be re–imaged every 6–12 months.
Size threshold smaller in females, in those with small body habitus, or those with family history of AAA or rupture.
Growth velocity >0.5 cm/year may be an indication for repair.
Symptoms always constitute an indication for repair.
Suprarenal AAA (or thoracoabdominal aneurysms, see below) may be repaired at sizes of 5.5–6.0 cm.
Surgical repair of AAA
Resection of aneurysm and replacement with a synthetic graft.
Endovascular aortic aneurysm repair (EVAR) [6–9]
Percutaneous fluoroscopically-guided deployment of an expanding endovascular stent inside the aneurysm and attached to the aorta at the proximal and distal aneurysm margins, thereby excluding the aneurysm from aortic blood flow.
Only about half of AAA patients have anatomy suitable for EVAR: anatomic considerations include aneurysm length, proximal and distal landing zones, tortuosity, aneurysm thrombus or calcium, iliac artery diameter.
EVAR reduces peri- and immediate post-procedure morbidity and mortality and post-operative hospitalization, but whether the long-term outcomes are improved or are as durable as open surgical repair remains under investigation. Randomized trials suggest no difference in long-term mortality (EVAR-1, DREAM and OVER trials), although a single retrospective Medicare analysis from 2012 suggests higher all-cause mortality at 2.5 years from open repair vs. EVAR [9].
Endoleak: EVAR is associated with endoleak, or persistent blood flow into the aneurysm sac due to inability to completely exclude it from circulation.
Post-EVAR patients require imaging surveillance at 1, 6, and 12-months, in order to monitor for endoleaks, assess graft position, check aneurysm sac size, and gauge need for reintervention (class I).
Repair endoleaks that leak into aneurysm sac around an imperfect seal at proximal and/or distal anastomosis of stent graft OR structural defect, e.g. tear, stent fracture, etc.
EVAR patients have an approximately 10 % higher reintervention rate at 6 years compared to open repair.
The 2011 ACC/AHA guidelines on peripheral artery disease (PAD) give a class I recommendation for “open or endovascular repair of infrarenal AAAs” in “good surgical candidates.”
There is a class IIa recommendation for open AAA repair in good surgical candidates who could not comply with surveillance imaging post-EVAR.
Due to short-term advantages, EVAR has been considered for higher risk patients (e.g. older, high perioperative risks). However, the EVAR-2 trial studied patients deemed “physically ineligible” to undergo open repair and found no improvement in all-cause mortality versus medical therapy alone.
The 2011 ACC/AHA PAD guidelines give EVAR a class IIb recommendation in high risk surgical patients (uncertain benefit in this group).
Thoracic Aortic Aneurysm (TAA)
Epidemiology: TAA is believed to be about one-third as common as AAA. Because TAA is a clinically silent disease, the incidence is estimated from autopsy series at 3–4%.
TAA is most commonly seen >age 50; the age of onset is earlier than for AAA.
Male:Female ratio is ∼2:1, as compared to AAA which has a much higher ratio.
Anatomic location:
Ascending aorta: 60 %
Root aneurysms are associated with Marfan syndrome, and ascending aortic aneurysms with bicuspid aortic valve or sporadic aneurysms.
Arch: 10 %
Descending thoracic aorta: 40 %
Thoracoabdominal (see below): <10 %
Multiple aneurysms: <10 %
Etiology [10–12]:Get Clinical Tree app for offline access
HTN and atherosclerosis are the primary risk factors for non-syndromic descending and thoracoabdominal aneurysms.
For root and ascending aneurysms, medial degeneration is the final common etiopathologic pathway.
Medial degeneration may be acquired (e.g. HTN) or congenital (e.g. Marfan syndrome).
Medial degeneration (previously called cystic medial necrosis), involves smooth muscle cell apoptosis, elastic fiber degeneration (particularly important in Marfan syndrome), and infiltration of subintimal spaces with mucoid proteoglycan.
MMP’s are also implicated.
Bicuspid aortic valve (AV) is the most common cardiac congenital anomaly (∼1–2 % population prevalence; Male:Female ration is 3:1), and is associated with TAA, dissection, and coarctation [13].
BAV is associated with aortic medial degeneration.
Genetic TAA syndromes:
Marfan syndrome: Besides thoracic aortopathy, manifestations include valvular, skeletal, and ocular pathology. The etiology is an autosomal dominant defect in fibrillin-1, a structural glycoprotein in the extracellular matrix of the aorta media. Fibrillin-1 is also involved in downregulating the activity of TGF-beta.
Aortic root dilatation is present in 80 % of Marfan adults. Aneurysms may also appear in carotid/other cerebral arteries and the abdominal aorta.< div class='tao-gold-member'>Only gold members can continue reading. Log In or Register a > to continue
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree